PMC:7696151 / 21431-21640 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"615","span":{"begin":154,"end":162},"obj":"Species"},{"id":"618","span":{"begin":187,"end":198},"obj":"Species"},{"id":"626","span":{"begin":74,"end":77},"obj":"Chemical"},{"id":"627","span":{"begin":113,"end":116},"obj":"Chemical"},{"id":"628","span":{"begin":121,"end":134},"obj":"Chemical"},{"id":"642","span":{"begin":199,"end":208},"obj":"Disease"}],"attributes":[{"id":"A615","pred":"tao:has_database_id","subj":"615","obj":"Tax:9606"},{"id":"A618","pred":"tao:has_database_id","subj":"618","obj":"Tax:37124"},{"id":"A626","pred":"tao:has_database_id","subj":"626","obj":"MESH:D006886"},{"id":"A627","pred":"tao:has_database_id","subj":"627","obj":"MESH:D008727"},{"id":"A628","pred":"tao:has_database_id","subj":"628","obj":"MESH:D012460"},{"id":"A642","pred":"tao:has_database_id","subj":"642","obj":"MESH:D001168"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In particular, in a randomized controlled open-label study, the impact of HCQ in monotherapy or association with MTX and sulfasalazine was assessed in 72 patients with chronic persistent chikungunya arthritis."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T21","span":{"begin":199,"end":208},"obj":"Phenotype"}],"attributes":[{"id":"A21","pred":"hp_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/HP_0001369"}],"text":"In particular, in a randomized controlled open-label study, the impact of HCQ in monotherapy or association with MTX and sulfasalazine was assessed in 72 patients with chronic persistent chikungunya arthritis."}

{"project":"LitCovid-sentences","denotations":[{"id":"T152","span":{"begin":0,"end":209},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In particular, in a randomized controlled open-label study, the impact of HCQ in monotherapy or association with MTX and sulfasalazine was assessed in 72 patients with chronic persistent chikungunya arthritis."}